Helptext

Latest News

DateTimeSubject
8/19/20108:14 AMNeuroVive: Halvårsrapport 2010-01-01 till 2010-06-30
7/21/201012:03 PMNeuroVive: NeuroVive erhåller positivt COMP beslut avseende Orphan Drug Designation i Europa
6/15/201012:03 PMNeuroVive: NeuroVive ansöker om Orphan Drug Designation i Europa

Graph with closing prices (blue curve) and volumes (red bars)

Graph for NeuroVive Pharmaceutical
 
Choose Date Horizon > 3 years 3 years 1 year 3 months 1 month 1 week Today

Company Information

Company NameNeuroVive Pharmaceutical AB
Company Idea

NeuroVive bedriver avancerad forskning och klinisk utveckling av nervcellsskyddande läkemedel för akuta hjärnskador som i dagsläget helt saknar effektiva behandlingsmöjligheter. Bolagets första patenterade produkt NeuroSTAT® är färdig för kliniska prövningar i människa. NeuroVive avser att utlicensiera produkter till större läkemedelsföretag för registrering, marknadsföring och försäljning.
CEOMikael BrönnegårdChairm. of the BoardGregory Batcheller
Phone046-288 01 10Fax046-888 83 48
Homepagehttp://www.neurovive.seE-mailinfo(snabel-a)neurovive(punkt)se

Instrument Information

Full NameNeuroVive Pharmaceutical ABShort NameNVP
Trading Lot1Ratio Value0.05
No of shares14,942,857ISIN codeSE0002575340
TypeShare

Price Information

+/-(0.40)
%-1.34
Latest29.50
High29.80
Low28.00
Volume31,137
Turnover907,266
Market Cap441

Orders

VolumeBidAskVolume
10028.9029.50378
29728.8029.60500
26028.7029.80500
5028.6029.90908
80028.5030.00574
58028.3030.40300
1,00028.2030.70444
4,37528.0030.90200
50027.0031.10200
50026.8031.801,000
57226.5032.00540
40026.2034.30661
3,00026.0035.801,100
15025.7036.70600
1,10025.0038.50300
1,22024.7040.30300
80024.5042.10300
53924.1044.80300
2,00024.0047.50300
60022.3050.50300

Deals

TimeBuyerSellerPriceVolume
5:29 PMNONNDS29.5022
5:29 PMNONENS29.50178
5:14 PMNONENS29.30280
5:11 PMNONENS29.3092
5:11 PMNONNON29.30200
5:08 PMAVAAVA29.005
5:08 PMENSAVA28.80195
5:07 PMNONAVA28.90300
5:07 PMENSAVA28.808
5:07 PMNONAVA28.9092

Scheduled Reports

DateReport
2010-11-18Delårsrapport tre
2011-02-22Bokslutskommuniké för 2010
More transactions

Latest Insider Transactions

DateTickerNameChange
5/5/2010NVPEskil Elmér3,214
5/5/2010NVPEskil Elmér142
5/5/2010NVPAndreas Inghammar2,500
5/5/2010NVPAndreas Inghammar71
5/5/2010NVPAndreas Inghammar142
5/5/2010NVPAndreas Inghammar142
5/5/2010NVPEskil Elmér71
5/5/2010NVPMarcus Keep10,000
5/5/2010NVPZaza Kokaia2,947
5/5/2010NVPMerab Kokaia5,108
 
Items marked in italic are transactions done by persons closely associeated with the named insiders, or legal entities associated with the named insider
Items marked in red are either transactions that have been reported late or corrections for wrongly reported transactions to AktieTorget.
Items marked in gray are transactions on persons who no longer are registered as insiders on the company.
* = Closely held endowment insurance
(*) = Named personal company




  • Danderydsgatan 10
  • 114 86 Stockholm
  • Telefon: 08 - 545 038 00
  • Fax: 08 - 611 35 62
  • info(snabel-a)aktietorget(punkt)se